Home > National Drug Code (NDC) > Treatment Set TS351201

Treatment Set TS351201 - 49288-0955-3 - (Treatment Set TS351201)

Alphabetical Index


Drug Information of Treatment Set TS351201

Product NDC: 49288-0955
Proprietary Name: Treatment Set TS351201
Non Proprietary Name: Treatment Set TS351201
Active Ingredient(s): .01; .002; .01; 400; 2000; .002; 4000; .002    g/mL; g/mL; g/mL; [BAU]/mL; [AU]/mL; g/mL; [BAU]/mL; g/mL & nbsp;   Treatment Set TS351201
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Treatment Set TS351201

Product NDC: 49288-0955
Labeler Name: Antigen Laboratories, Inc.
Product Type: NON-STANDARDIZED ALLERGENIC
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19861031

Package Information of Treatment Set TS351201

Package NDC: 49288-0955-3
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (49288-0955-3)

NDC Information of Treatment Set TS351201

NDC Code 49288-0955-3
Proprietary Name Treatment Set TS351201
Package Description 10 mL in 1 VIAL, MULTI-DOSE (49288-0955-3)
Product NDC 49288-0955
Product Type Name NON-STANDARDIZED ALLERGENIC
Non Proprietary Name Treatment Set TS351201
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19861031
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name ALTERNARIA ALTERNATA; AVENA SATIVA POLLEN; COCHLIOBOLUS SATIVUS; CYNODON DACTYLON POLLEN; DERMATOPHAGOIDES PTERONYSSINUS; PASCOPYRUM SMITHII POLLEN; PHLEUM PRATENSE POLLEN; SORGHUM HALEPENSE POLLEN
Strength Number .01; .002; .01; 400; 2000; .002; 4000; .002
Strength Unit g/mL; g/mL; g/mL; [BAU]/mL; [AU]/mL; g/mL; [BAU]/mL; g/mL
Pharmaceutical Classes Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Insect Protein Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Treatment Set TS351201


General Information